Tenax Therapeutics, Inc. (NASDAQ:TENX) Posts Basic Consolidated EPS Of $-0.5015

0

Tenax Therapeutics, Inc. (NASDAQ:TENX)managed to report annual basic consolidated EPS of $-0.5015, which was for the year ended2015-04-30.The company reported basic consolidated EPS of $-0.5015 for the quarter ended 2015-04-30.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-04-30. As for the quarter ended 2015-04-30, continuing operations produced EPS of $-0.1651.

EPS contribution from parent

Tenax Therapeutics, Inc. (NASDAQ:TENX) received of $-0.5015 EPS boost from the parent company for the annual period ended

For the year ended 2015-04-30, the parent of Tenax Therapeutics, Inc. (NASDAQ:TENX) contributed EPS of $-0.5015 to the company’s bottom-line. But for the quarter ended 2015-04-30, EPS boost from the parent was cited as $-0.5015.

What About Basic net EPS

The basic net EPS that Tenax Therapeutics, Inc. (NASDAQ:TENX) reported for the year ended 2015-04-30 stood at $-0.5. For the quarter ended 2015-04-30, the company posted basic net EPS of $-0.5.

What About Consolidated Diluted EPS?

Tenax Therapeutics, Inc. (NASDAQ:TENX)’s consolidated diluted EPS for the year ended 2015-04-30 was reported as $-0.5015. For the quarter ended 2015-04-30 the metric was$-0.5015.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $-0.5015 for the yearended 2015-04-30. But diluted EPS from continuing operations for the quarter ended 2015-04-30 came in at $-0.5015.

Net diluted EPS

Net diluted EPS posted by Tenax Therapeutics, Inc. (NASDAQ:TENX) for the year ended 2015-04-30 was $-0.5. On quarterly basis, net diluted EPS for the quarter ended 2015-04-30 was reported as $-0.5.

What portion of diluted EPS came from parent?

For the annual period ended 2015-04-30, the parent company of Tenax Therapeutics, Inc. (NASDAQ:TENX) said that it parent company boosted its diluted EPS by$-0.5015 in the year ended 2015-04-30. For the quarter ended 2015-04-30, the parent company’s contribution to diluted EPS was $-0.5015.

The company reported net basic EPS of $-0.5 for the year ended 2015-04-30 and net basic EPS of $-0.5 for the quarter ended 2015-04-30.

The number of Tenax Therapeutics, Inc. (NASDAQ:TENX)’s basic shares outstanding at the end of the annual period ended 2015-04-30 was 28.078. That compares with 28.078 basic shares outstanding for the quarter ended 2015-04-30.

Tenax Therapeutics, Inc. (NASDAQ:TENX) had 28.078 diluted shares outstanding at the end of the annual period ended 2015-04-30. But for the quarter ended 2015-04-30, diluted outstanding shares were 28.078.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 22 times, 1 visits today)